Machine Learning Model Can Predict Autism Spectrum Disorder
By Elana Gotkine HealthDay Reporter
MONDAY, Aug. 19, 2024 -- In a diagnostic study, machine learning (ML) can predict autism spectrum disorder (ASD), according to a study published online Aug. 19 in JAMA Network Open.
Shyam Sundar Rajagopalan, Ph.D., from the Karolinska Institutet in Stockholm, and colleagues developed and validated an ML model for predicting ASD using a minimal set of features from background and medical information. A retrospective analysis of the Simons Foundation Powering Autism Research for Knowledge database was conducted, including data from 30,660 participants (15,330 with and 15,330 without ASD). Generalizable ML prediction models were developed using four algorithms: logistic regression, decision tree, random forest, and eXtreme Gradient Boosting (XGBoost).
The researchers found that the XGBoost model demonstrated strong performance, with an area under the receiver operating characteristic curve (AUROC) score of 0.895; sensitivity and specificity of 0.805 and 0.829, respectively; and a positive predictive value of 0.897. The most important predictors were developmental milestones and eating behavior. An AUROC of 0.790 was seen on validation on independent cohorts, indicating good generalizability.
"Early medical information in child care clinics can be used to screen for those with a higher probability of being diagnosed with ASD," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted August 2024
Read this next
Declining Childhood Vaccination May Increase Risk for Vaccine-Preventable Infections
WEDNESDAY, April 30, 2025 -- Declining childhood vaccination rates may increase outbreaks of eliminated vaccine-preventable infections within the United States, leading to a...
AACR: Incidence-Based Mortality Dropping for Young Women With Breast Cancer
TUESDAY, April 29, 2025 -- Incidence-based mortality (IBM) declined from 2010 to 2020 among women aged 20 to 49 years diagnosed with breast cancer, according to a study presented...
AACR: Nonsurgical Treatment Feasible for Mismatch Repair-Deficient Tumors
TUESDAY, April 29, 2025 -- A neoadjuvant programmed cell death 1 (PD-1) blockade enables nonoperative management among patients with early-stage mismatch repair-deficient (dMMR)...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.